Article references (11 references )


  1. Abraham-Nordling M, Bystrom K, Torring O et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol. 2011; 6 (165):899-905. PubMed | Google Scholar

  2. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab. Juin 1987; 64 (6):1241-5. PubMed | Google Scholar

  3. Weetman AP. Graves' hyperthyroidism. Nat Clin Pract Endocrinol Metab. Janvier 2006; 2 (1): 2-3.

  4. Léger J et al. Graves'disease in children. Best Practice & Research Clinical Endocrinology & Metabolism. Mars 2014; 28(2):233-243.

  5. Rivkees SA, Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab. Avril 2010; 95 (7): 3260-3267. PubMed | Google Scholar

  6. Rivkees SA, Dinauer C. An optimal treatment for pediatric graves' disease is radioiodine. J Clin Endocrinol Metab. Mars 2007; 92 (3):797-800. PubMed | Google Scholar

  7. Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab. Juin 1997; 82 (6):1719-26. PubMed | Google Scholar

  8. Glaser NS, Styne DM. Predicting the likelihood of remission in chidren with Graves' disease: prospective, multicenter study. Pediatrics. Mars 2008; 121 (3):481-8. PubMed | Google Scholar

  9. Lazar L et al. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab. Octobre 2000; 85 (10):3678-82. PubMed | Google Scholar

  10. Merad MS et al. Hyperthyroidie chez l'enfant et l'adolescent : aspects cliniques, évolutifs et thérapeutiques. Annales d'Endocrinologie. septembre 2013;74 (4):369. Google Scholar

  11. Read CH, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young graves' patients'. J Clin Endocrinol Metab. Septembre 2004; 89 (9):4229-33. PubMed | Google Scholar